α-MSH
Based on 24 publication(s) in Google Scholar
α-MSH (α-Melanocyte-Stimulating Hormone), an endogenous neuropeptide, is an endogenous melanocortin receptor 4 (MC4R) agonist with anti-inflammatory and antipyretic activities. α-MSH is a post-translational derivative of pro-opiomelanocortin (POMC).
For research use only. We do not sell to patients.
- Purity: 99.98%
- CAS No.: 581-05-5
- Formula: C77H109N21O19S
- Molecular Weight:1664.88
-
Storage:
Sealed storage, away from moisture and light, under nitrogen.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)
Publications Citing Use of MedChemExpress (MCE) α-MSH
More- Nat Commun. 2023 Sep 15;14(1):5740. [Abstract]
- Phytomedicine. 2026 Apr:153:157963. [Abstract]
- Mater Today Bio. 2026 May 27. [Abstract]
- J Hazard Mater. 2024 May 15:470:134112. [Abstract]
- Acta Pharmacol Sin. 2025 Jul;46(7):1892-1904. [Abstract]
- Antioxidants (Basel). 2026 Mar 11;15(3):350. [Abstract]
- Antioxidants (Basel). 2022 Jul 2;11(7):1317. [Abstract]
- Free Radic Biol Med. 2021 Nov 20:176:392-405. [Abstract]
- Stem Cell Res Ther. 2021 Sep 10;12(1):501. [Abstract]
- Blood Adv. 2023 Jul 11;7(13):3199-3212. [Abstract]
- J Med Chem. 2024 Nov 14;67(21):19323-19341. [Abstract]
- Postharvest Biol Technol. 2024 Feb, 208, 112645.
- J Ethnopharmacol. 2024 May 23:326:117933. [Abstract]
- J Agric Food Chem. 2023 Nov 1;71(43):16090-16101. [Abstract]
- Foods. 2026 Feb 1;15(3):507. [Abstract]
- Colloids Surf B Biointerfaces. 2025 Jul 24:255:114979. [Abstract]
- Bioorg Chem. 2024 Nov:152:107758. [Abstract]
- Algal Res. 2025 Jun.
- J Photochem Photobiol B. 2025 Nov:272:113277. [Abstract]
- Photochem Photobiol Sci. 2025 Oct;24(10):1763-1779. [Abstract]
- J Cosmet Dermatol. 2023 Oct;22(10):2824-2830. [Abstract]
- Int J Cosmet Sci. 2025 Feb;47(1):31-44. [Abstract]
- Journal of Dermatologic Science and Cosmetic Technology. 2025 Jan 11.
- Heliyon. 2024 Aug 7;10(15):e35295. [Abstract]
-
RT-PCR
-
Cell Proliferation/Viability Assay
-
WB
-
Flow Cytometry
-
Bio/Physico-chemical Assay
Biological Activity
|
MC4R |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | EC50 |
1.1 nM
Compound: alpha-MSH
|
Effective concentration towards human melanocortin-3 receptor mediated cAMP accumulation in CHO cells
Effective concentration towards human melanocortin-3 receptor mediated cAMP accumulation in CHO cells
|
[PMID: 15582434] |
| CHO | EC50 |
1.9 nM
Compound: alpha-MSH
|
Effective concentration towards human melanocortin-4 receptor mediated cAMP accumulation in CHO cells
Effective concentration towards human melanocortin-4 receptor mediated cAMP accumulation in CHO cells
|
[PMID: 15582434] |
| CHO | EC50 |
17 nM
Compound: alpha-MSH
|
Effective concentration towards human melanocortin-5 receptor mediated cAMP accumulation in CHO cells
Effective concentration towards human melanocortin-5 receptor mediated cAMP accumulation in CHO cells
|
[PMID: 15582434] |
| CHO | IC50 |
19 nM
Compound: alpha-MSH
|
Concentration for 50% inhibition of human melanocortin-4 receptor expressed in CHO cells using [125I]NDP-alpha-MSH as radioligand
Concentration for 50% inhibition of human melanocortin-4 receptor expressed in CHO cells using [125I]NDP-alpha-MSH as radioligand
|
[PMID: 15582434] |
| CHO | IC50 |
19 nM
Compound: alpha-MSH
|
Inhibitory concentration to displace [125I]-NDP-alpha-MSH from human melanocortin 4 receptor expressed in CHO cells
Inhibitory concentration to displace [125I]-NDP-alpha-MSH from human melanocortin 4 receptor expressed in CHO cells
|
[PMID: 15808454] |
| CHO | EC50 |
1.1 nM
Compound: Alpha-MSH
|
Inhibition concentration (binding affinity) exhibited against human melanocortin receptor 3 by radio labeled ligand assay (Displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells)
Inhibition concentration (binding affinity) exhibited against human melanocortin receptor 3 by radio labeled ligand assay (Displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells)
|
[PMID: 15982875] |
| CHO | EC50 |
1.9 nM
Compound: Alpha-MSH
|
Inhibition concentration (binding affinity) exhibited against human melanocortin receptor 4 by radio labeled ligand assay (Displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells)
Inhibition concentration (binding affinity) exhibited against human melanocortin receptor 4 by radio labeled ligand assay (Displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells)
|
[PMID: 15982875] |
| CHO | EC50 |
17 nM
Compound: Alpha-MSH
|
Inhibition concentration (binding affinity) exhibited against human melanocortin receptor 5 by radio labeled ligand assay (Displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells)
Inhibition concentration (binding affinity) exhibited against human melanocortin receptor 5 by radio labeled ligand assay (Displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells)
|
[PMID: 15982875] |
| CHO | IC50 |
118 nM
Compound: Alpha-MSH
|
Inhibition concentration (binding affinity) against human melanocortin receptor 5 by displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells
Inhibition concentration (binding affinity) against human melanocortin receptor 5 by displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells
|
[PMID: 15982875] |
| CHO | IC50 |
19 nM
Compound: Alpha-MSH
|
Inhibition concentration (binding affinity) against human melanocortin receptor 3 by displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells
Inhibition concentration (binding affinity) against human melanocortin receptor 3 by displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells
|
[PMID: 15982875] |
| CHO | IC50 |
19 nM
Compound: Alpha-MSH
|
Inhibition concentration (binding affinity) against human melanocortin receptor 4 by displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells
Inhibition concentration (binding affinity) against human melanocortin receptor 4 by displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells
|
[PMID: 15982875] |
| CHO | EC50 |
0.0027 μM
Compound: alpha-MSH
|
Agonist activity at human recombinant MC3 receptor expressed in CHO cells assessed as cAMP accumulation by enzyme fragment complementation assay
Agonist activity at human recombinant MC3 receptor expressed in CHO cells assessed as cAMP accumulation by enzyme fragment complementation assay
|
[PMID: 20329799] |
| CHO | EC50 |
2.2 nM
Compound: alpha-MSH
|
Agonist activity at human recombinant MC4 receptor expressed in CHO cells by cAMP responsive beta lactamase reporter gene assay
Agonist activity at human recombinant MC4 receptor expressed in CHO cells by cAMP responsive beta lactamase reporter gene assay
|
[PMID: 20329799] |
| HEK293 | EC50 |
0.44 nM
Compound: alpha-MSH
|
Activity in mouse melanocortin-5 receptor stably expressed in HEK293 cells
Activity in mouse melanocortin-5 receptor stably expressed in HEK293 cells
|
[PMID: 12477357] |
| HEK293 | EC50 |
0.55 nM
Compound: alpha-MSH
|
Activity in mouse melanocortin-1 receptor stably expressed in HEK293 cells
Activity in mouse melanocortin-1 receptor stably expressed in HEK293 cells
|
[PMID: 12477357] |
| HEK293 | EC50 |
0.79 nM
Compound: alpha-MSH
|
Activity in mouse melanocortin-3 receptor (mMC3R) stably expressed in HEK293 cells
Activity in mouse melanocortin-3 receptor (mMC3R) stably expressed in HEK293 cells
|
[PMID: 12477357] |
| HEK293 | EC50 |
5.37 nM
Compound: alpha-MSH
|
Activity in mouse melanocortin-4 receptor stably expressed in HEK293 cells
Activity in mouse melanocortin-4 receptor stably expressed in HEK293 cells
|
[PMID: 12477357] |
| HEK293 | EC50 |
0.32 μM
Compound: alpha-MSH
|
Compound was evaluated for its agonist activity on mouse melanocortin 1 receptor (mMC1R) stably expressed in HEK cells
Compound was evaluated for its agonist activity on mouse melanocortin 1 receptor (mMC1R) stably expressed in HEK cells
|
[PMID: 12781199] |
| HEK293 | EC50 |
1.21 μM
Compound: alpha-MSH
|
Compound was evaluated for its agonist activity on mouse melanocortin receptor 3 (mMC3R) stably expressed in HEK cells
Compound was evaluated for its agonist activity on mouse melanocortin receptor 3 (mMC3R) stably expressed in HEK cells
|
[PMID: 12781199] |
| HEK293 | EC50 |
1.4 nM
Compound: alpha-MSH
|
In vitro cAMP accumulation in HEK cells transfected with human Melanocortin 3 receptor (hMC3R)
In vitro cAMP accumulation in HEK cells transfected with human Melanocortin 3 receptor (hMC3R)
|
[PMID: 14552781] |
| HEK293 | EC50 |
1.6 nM
Compound: alpha-MSH
|
In vitro cAMP accumulation in HEK cells transfected with human Melanocortin 1 receptor (hMC1R)
In vitro cAMP accumulation in HEK cells transfected with human Melanocortin 1 receptor (hMC1R)
|
[PMID: 14552781] |
| HEK293 | EC50 |
29 nM
Compound: alpha-MSH
|
In vitro cAMP accumulation in HEK cells transfected with human Melanocortin 5 receptor (hMC5R)
In vitro cAMP accumulation in HEK cells transfected with human Melanocortin 5 receptor (hMC5R)
|
[PMID: 14552781] |
| HEK293 | EC50 |
6.1 nM
Compound: alpha-MSH
|
In vitro cAMP accumulation in HEK cells transfected with human melanocortin receptor-4 (hMC4R)
In vitro cAMP accumulation in HEK cells transfected with human melanocortin receptor-4 (hMC4R)
|
[PMID: 14552781] |
| HEK293 | EC50 |
0.4 nM
Compound: Alpha-MSH
|
Agonistic activity evaluated at melanocortin 5 receptor (MC5R) of mouse HEK293 cells
Agonistic activity evaluated at melanocortin 5 receptor (MC5R) of mouse HEK293 cells
|
[PMID: 14643357] |
| HEK293 | EC50 |
0.6 nM
Compound: Alpha-MSH
|
Agonistic activity evaluated at melanocortin 1 receptor (MC1R) of mouse HEK293 cells
Agonistic activity evaluated at melanocortin 1 receptor (MC1R) of mouse HEK293 cells
|
[PMID: 14643357] |
| HEK293 | EC50 |
0.8 nM
Compound: Alpha-MSH
|
Agonistic activity evaluated at melanocortin 3 receptor (MC3R) of mouse HEK293 cells
Agonistic activity evaluated at melanocortin 3 receptor (MC3R) of mouse HEK293 cells
|
[PMID: 14643357] |
| HEK293 | EC50 |
5.4 nM
Compound: Alpha-MSH
|
Agonistic activity evaluated at melanocortin 4 receptor (MC4R) of mouse HEK293 cells
Agonistic activity evaluated at melanocortin 4 receptor (MC4R) of mouse HEK293 cells
|
[PMID: 14643357] |
| HEK293 | EC50 |
0.28 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC1R expressed in HEK293 cells by beta-galactosidase assay
Agonist activity at mouse MC1R expressed in HEK293 cells by beta-galactosidase assay
|
[PMID: 15615519] |
| HEK293 | EC50 |
0.52 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC3R expressed in HEK293 cells by beta-galactosidase assay
Agonist activity at mouse MC3R expressed in HEK293 cells by beta-galactosidase assay
|
[PMID: 15615519] |
| HEK293 | EC50 |
1.12 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC5R expressed in HEK293 cells by beta-galactosidase assay
Agonist activity at mouse MC5R expressed in HEK293 cells by beta-galactosidase assay
|
[PMID: 15615519] |
| HEK293 | EC50 |
1.89 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC4R expressed in HEK293 cells by beta-galactosidase assay
Agonist activity at mouse MC4R expressed in HEK293 cells by beta-galactosidase assay
|
[PMID: 15615519] |
| HEK293 | EC50 |
0.7 nM
Compound: 14
|
Effective concentration for intracellular cAMP accumulation in human melanocortin 1 receptor expressing HEK 293 cells; (N = 4)
Effective concentration for intracellular cAMP accumulation in human melanocortin 1 receptor expressing HEK 293 cells; (N = 4)
|
[PMID: 15771429] |
| HEK293 | EC50 |
2.1 nM
Compound: 14
|
Effective concentration for intracellular cAMP accumulation in human melanocortin 4 receptor expressing HEK 293 cells; (N = 4)
Effective concentration for intracellular cAMP accumulation in human melanocortin 4 receptor expressing HEK 293 cells; (N = 4)
|
[PMID: 15771429] |
| HEK293 | EC50 |
6.7 nM
Compound: 14
|
Effective concentration for intracellular cAMP accumulation in human melanocortin 3 receptor expressing HEK 293 cells; (N = 4)
Effective concentration for intracellular cAMP accumulation in human melanocortin 3 receptor expressing HEK 293 cells; (N = 4)
|
[PMID: 15771429] |
| HEK293 | EC50 |
8.1 nM
Compound: 14
|
Effective concentration for intracellular cAMP accumulation in human melanocortin 5 receptor expressing HEK 293 cells; (N = 4)
Effective concentration for intracellular cAMP accumulation in human melanocortin 5 receptor expressing HEK 293 cells; (N = 4)
|
[PMID: 15771429] |
| HEK293 | IC50 |
0.4 nM
Compound: 14
|
Inhibition of [125I]NDP-MSH binding to Melanocortin 1 receptor expressed in HEK293 cells; (N = 4)
Inhibition of [125I]NDP-MSH binding to Melanocortin 1 receptor expressed in HEK293 cells; (N = 4)
|
[PMID: 15771429] |
| HEK293 | IC50 |
18 nM
Compound: 14
|
Inhibition of [125I]NDP-MSH binding to Melanocortin 5 receptor expressed in HEK293 cells; N = 4
Inhibition of [125I]NDP-MSH binding to Melanocortin 5 receptor expressed in HEK293 cells; N = 4
|
[PMID: 15771429] |
| HEK293 | IC50 |
30 nM
Compound: 14
|
Inhibition of [125I]NDP-MSH binding to Melanocortin 3 receptor expressed in HEK293 cells; (N = 4)
Inhibition of [125I]NDP-MSH binding to Melanocortin 3 receptor expressed in HEK293 cells; (N = 4)
|
[PMID: 15771429] |
| HEK293 | IC50 |
5 nM
Compound: 14
|
Inhibition of [125I]NDP-MSH binding to Melanocortin 4 receptor expressed in HEK293 cells; (N = 4)
Inhibition of [125I]NDP-MSH binding to Melanocortin 4 receptor expressed in HEK293 cells; (N = 4)
|
[PMID: 15771429] |
| HEK293 | EC50 |
1.8 nM
Compound: alpha-MSH
|
Agonist activity at the mutant MC4R F184A expressed in HEK293 cells by cAMP accumulation
Agonist activity at the mutant MC4R F184A expressed in HEK293 cells by cAMP accumulation
|
[PMID: 16451057] |
| HEK293 | EC50 |
156 nM
Compound: alpha-MSH
|
Agonist activity at the mutant MC4R Y287A expressed in HEK293 cells by cAMP accumulation
Agonist activity at the mutant MC4R Y287A expressed in HEK293 cells by cAMP accumulation
|
[PMID: 16451057] |
| HEK293 | EC50 |
18 nM
Compound: alpha-MSH
|
Agonist activity at the mutant MC4R F184L expressed in HEK293 cells by cAMP accumulation
Agonist activity at the mutant MC4R F184L expressed in HEK293 cells by cAMP accumulation
|
[PMID: 16451057] |
| HEK293 | EC50 |
2.6 nM
Compound: alpha-MSH
|
Agonist activity at the mutant MC4R Y287F expressed in HEK293 cells by cAMP accumulation
Agonist activity at the mutant MC4R Y287F expressed in HEK293 cells by cAMP accumulation
|
[PMID: 16451057] |
| HEK293 | EC50 |
2.9 nM
Compound: alpha-MSH
|
Agonist activity at the human wild type MC4R expressed in HEK293 cells by cAMP accumulation
Agonist activity at the human wild type MC4R expressed in HEK293 cells by cAMP accumulation
|
[PMID: 16451057] |
| HEK293 | EC50 |
21 nM
Compound: alpha-MSH
|
Agonist activity at the mutant MC4R I125A expressed in HEK293 cells by cAMP accumulation
Agonist activity at the mutant MC4R I125A expressed in HEK293 cells by cAMP accumulation
|
[PMID: 16451057] |
| HEK293 | EC50 |
21 nM
Compound: alpha-MSH
|
Agonist activity at the mutant MC4R Y268A expressed in HEK293 cells by cAMP accumulation
Agonist activity at the mutant MC4R Y268A expressed in HEK293 cells by cAMP accumulation
|
[PMID: 16451057] |
| HEK293 | EC50 |
27 nM
Compound: alpha-MSH
|
Agonist activity at the mutant MC4R I129A expressed in HEK293 cells by cAMP accumulation
Agonist activity at the mutant MC4R I129A expressed in HEK293 cells by cAMP accumulation
|
[PMID: 16451057] |
| HEK293 | EC50 |
7.1 nM
Compound: alpha-MSH
|
Agonist activity at the mutant MC4R Y268F expressed in HEK293 cells by cAMP accumulation
Agonist activity at the mutant MC4R Y268F expressed in HEK293 cells by cAMP accumulation
|
[PMID: 16451057] |
| HEK293 | EC50 |
89 nM
Compound: alpha-MSH
|
Agonist activity at the mutant MC4R I291A expressed in HEK293 cells by cAMP accumulation
Agonist activity at the mutant MC4R I291A expressed in HEK293 cells by cAMP accumulation
|
[PMID: 16451057] |
| HEK293 | EC50 |
0.7 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC1R expressed in HEK293 cells assessed as forskolin-stimulated response by beta-galactosidase reporter gene assay
Agonist activity at mouse MC1R expressed in HEK293 cells assessed as forskolin-stimulated response by beta-galactosidase reporter gene assay
|
[PMID: 18271518] |
| HEK293 | EC50 |
2 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC5R expressed in HEK293 cells assessed as forskolin-stimulated response by beta-galactosidase reporter gene assay
Agonist activity at mouse MC5R expressed in HEK293 cells assessed as forskolin-stimulated response by beta-galactosidase reporter gene assay
|
[PMID: 18271518] |
| HEK293 | EC50 |
2.14 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC3R expressed in HEK293 cells assessed as forskolin-stimulated response by beta-galactosidase reporter gene assay
Agonist activity at mouse MC3R expressed in HEK293 cells assessed as forskolin-stimulated response by beta-galactosidase reporter gene assay
|
[PMID: 18271518] |
| HEK293 | EC50 |
2.56 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC4R expressed in HEK293 cells assessed as forskolin-stimulated response by beta-galactosidase reporter gene assay
Agonist activity at mouse MC4R expressed in HEK293 cells assessed as forskolin-stimulated response by beta-galactosidase reporter gene assay
|
[PMID: 18271518] |
| HEK293 | EC50 |
0.36 μM
Compound: alpha-MSH
|
Agonist activity at human recombinant MC5 receptor expressed in HEK293 cells assessed as cAMP accumulation by beta lactamase reporter gene assay
Agonist activity at human recombinant MC5 receptor expressed in HEK293 cells assessed as cAMP accumulation by beta lactamase reporter gene assay
|
[PMID: 20329799] |
| HEK293 | EC50 |
0.0009 μM
Compound: alpha-MSH
|
Agonist activity at human recombinant MC1 receptor expressed in HEK293 cells assessed as cAMP accumulation by enzyme fragment complementation assay
Agonist activity at human recombinant MC1 receptor expressed in HEK293 cells assessed as cAMP accumulation by enzyme fragment complementation assay
|
[PMID: 20329799] |
| HEK293 | EC50 |
0.9 nM
Compound: alpha-MSH
|
Agonist activity at human recombinant MC1 receptor expressed in HEK293 cells assessed as cAMP accumulation by enzyme fragment complementation assay
Agonist activity at human recombinant MC1 receptor expressed in HEK293 cells assessed as cAMP accumulation by enzyme fragment complementation assay
|
[PMID: 20329799] |
| HEK293 | EC50 |
0.65 nM
Compound: alpha-MSH
|
Agonist activity at wild type human melanocortin-4 receptor expressed in HEK293 cells co-transfected with CRE/beta-galactosidase reporter gene assessed as stimulatory response after 6 hrs
Agonist activity at wild type human melanocortin-4 receptor expressed in HEK293 cells co-transfected with CRE/beta-galactosidase reporter gene assessed as stimulatory response after 6 hrs
|
[PMID: 24517312] |
| HEK293 | EC50 |
0.22 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC5 receptor expressed in HEK-293 cells assessed as cAMP response measured after 2 hrs incubation by cAMP Alphascreen assay
Agonist activity at mouse MC5 receptor expressed in HEK-293 cells assessed as cAMP response measured after 2 hrs incubation by cAMP Alphascreen assay
|
[PMID: 26005535] |
| HEK293 | EC50 |
0.3 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC1 receptor expressed in HEK-293 cells assessed as cAMP response measured after 2 hrs incubation by cAMP Alphascreen assay
Agonist activity at mouse MC1 receptor expressed in HEK-293 cells assessed as cAMP response measured after 2 hrs incubation by cAMP Alphascreen assay
|
[PMID: 26005535] |
| HEK293 | EC50 |
0.4 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC3 receptor expressed in HEK-293 cells assessed as cAMP response measured after 2 hrs incubation by cAMP Alphascreen assay
Agonist activity at mouse MC3 receptor expressed in HEK-293 cells assessed as cAMP response measured after 2 hrs incubation by cAMP Alphascreen assay
|
[PMID: 26005535] |
| HEK293 | EC50 |
1.7 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC4 receptor expressed in HEK-293 cells assessed as cAMP response measured after 2 hrs incubation by cAMP Alphascreen assay
Agonist activity at mouse MC4 receptor expressed in HEK-293 cells assessed as cAMP response measured after 2 hrs incubation by cAMP Alphascreen assay
|
[PMID: 26005535] |
| HEK293 | EC50 |
0.14 nM
Compound: alpha-MSH
|
Agonist activity at mouse melanocortin 1 receptor expressed in HEK293 cells by AlphaScreen cAMP assay
Agonist activity at mouse melanocortin 1 receptor expressed in HEK293 cells by AlphaScreen cAMP assay
|
[PMID: 26433448] |
| HEK293 | EC50 |
0.5 nM
Compound: alpha-MSH
|
Agonist activity at mouse melanocortin 3 receptor expressed in HEK293 cells by AlphaScreen cAMP assay
Agonist activity at mouse melanocortin 3 receptor expressed in HEK293 cells by AlphaScreen cAMP assay
|
[PMID: 26433448] |
| HEK293 | EC50 |
0.51 nM
Compound: alpha-MSH
|
Agonist activity at mouse melanocortin 5 receptor expressed in HEK293 cells by AlphaScreen cAMP assay
Agonist activity at mouse melanocortin 5 receptor expressed in HEK293 cells by AlphaScreen cAMP assay
|
[PMID: 26433448] |
| HEK293 | EC50 |
2.9 nM
Compound: alpha-MSH
|
Agonist activity at mouse melanocortin 4 receptor expressed in HEK293 cells by AlphaScreen cAMP assay
Agonist activity at mouse melanocortin 4 receptor expressed in HEK293 cells by AlphaScreen cAMP assay
|
[PMID: 26433448] |
| HEK293 | EC50 |
0.15 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC1R expressed in HEK293 cells assessed as cAMP accumulation incubated for 2 hrs by alphascreen assay
Agonist activity at mouse MC1R expressed in HEK293 cells assessed as cAMP accumulation incubated for 2 hrs by alphascreen assay
|
[PMID: 26959173] |
| HEK293 | EC50 |
0.59 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC5R expressed in HEK293 cells assessed as cAMP accumulation incubated for 2 hrs by alphascreen assay
Agonist activity at mouse MC5R expressed in HEK293 cells assessed as cAMP accumulation incubated for 2 hrs by alphascreen assay
|
[PMID: 26959173] |
| HEK293 | EC50 |
0.76 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC3R expressed in HEK293 cells assessed as cAMP accumulation incubated for 2 hrs by alphascreen assay
Agonist activity at mouse MC3R expressed in HEK293 cells assessed as cAMP accumulation incubated for 2 hrs by alphascreen assay
|
[PMID: 26959173] |
| HEK293 | EC50 |
4 nM
Compound: alpha-MSH
|
Agonist activity at mouse MC4R expressed in HEK293 cells assessed as cAMP accumulation incubated for 2 hrs by alphascreen assay
Agonist activity at mouse MC4R expressed in HEK293 cells assessed as cAMP accumulation incubated for 2 hrs by alphascreen assay
|
[PMID: 26959173] |
| HEK293 | EC50 |
16.7 nM
Compound: alpha-MSH
|
Agonist activity at EYFP-fused human MC3R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
Agonist activity at EYFP-fused human MC3R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
|
[PMID: 28972753] |
| HEK293 | EC50 |
24.4 nM
Compound: alpha-MSH
|
Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells assessed as increase in cAMP accumulation after 30 mins by luminescent enzymatic complementation based assay
Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells assessed as increase in cAMP accumulation after 30 mins by luminescent enzymatic complementation based assay
|
[PMID: 28972753] |
| HEK293 | EC50 |
35.3 nM
Compound: alpha-MSH
|
Agonist activity at EYFP-fused human MC5R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
Agonist activity at EYFP-fused human MC5R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
|
[PMID: 28972753] |
| HEK293 | EC50 |
9.2 nM
Compound: alpha-MSH
|
Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay
|
[PMID: 28972753] |
| HEK293 | EC50 |
0.04 nM
Compound: alpha-MSH
|
Agonist activity at mouse melanocortin receptor 1 expressed in HEK293 cells assessed as stimulation of cAMP accumulation incubated for 2 hrs by cAMP AlphaScreen assay
Agonist activity at mouse melanocortin receptor 1 expressed in HEK293 cells assessed as stimulation of cAMP accumulation incubated for 2 hrs by cAMP AlphaScreen assay
|
[PMID: 32184956] |
| HEK293 | EC50 |
0.22 nM
Compound: alpha-MSH
|
Agonist activity at mouse melanocortin receptor 3 expressed in HEK293 cells assessed as stimulation of cAMP accumulation incubated for 2 hrs by cAMP Alpha-screen assay
Agonist activity at mouse melanocortin receptor 3 expressed in HEK293 cells assessed as stimulation of cAMP accumulation incubated for 2 hrs by cAMP Alpha-screen assay
|
[PMID: 32184956] |
| HEK293 | EC50 |
0.22 nM
Compound: alpha-MSH
|
Agonist activity at mouse melanocortin receptor 5 expressed in HEK293 cells assessed as stimulation of cAMP accumulation incubated for 2 hrs by cAMP Alpha-screen assay
Agonist activity at mouse melanocortin receptor 5 expressed in HEK293 cells assessed as stimulation of cAMP accumulation incubated for 2 hrs by cAMP Alpha-screen assay
|
[PMID: 32184956] |
| HEK293 | EC50 |
3.7 nM
Compound: alpha-MSH
|
Agonist activity at mouse melanocortin receptor 4 expressed in HEK293 cells assessed as stimulation of cAMP accumulation incubated for 2 hrs by cAMP Alpha-screen assay
Agonist activity at mouse melanocortin receptor 4 expressed in HEK293 cells assessed as stimulation of cAMP accumulation incubated for 2 hrs by cAMP Alpha-screen assay
|
[PMID: 32184956] |
| HEL | EC50 |
1.49 μM
Compound: alpha-MSH
|
Compound was evaluated for its agonist activity on mouse melanocortin 5 receptor (mMC5R) stably expressed in HEL cells
Compound was evaluated for its agonist activity on mouse melanocortin 5 receptor (mMC5R) stably expressed in HEL cells
|
[PMID: 12781199] |
| HEL | EC50 |
2.47 μM
Compound: alpha-MSH
|
Compound was evaluated for its agonist activity on mouse melanocortin 4 receptor (mMC4R) stably expressed in HEL cells
Compound was evaluated for its agonist activity on mouse melanocortin 4 receptor (mMC4R) stably expressed in HEL cells
|
[PMID: 12781199] |
| SAOS-2 | EC50 |
1.8 nM
Compound: alpha-MSH
|
Activity at human MC1R by cAMP accumulation in SaoS2 cells
Activity at human MC1R by cAMP accumulation in SaoS2 cells
|
[PMID: 16678415] |
| SAOS-2 | EC50 |
72.9 nM
Compound: alpha-MSH
|
Activity at human MC4R by cAMP accumulation in SaoS2 cells
Activity at human MC4R by cAMP accumulation in SaoS2 cells
|
[PMID: 16678415] |
α-MSH modulates CNS inflammation by acting directly on melanocortin receptors in glial cells. α-MSH modulates NFκB activation. α-MSH inhibits translocation of transcription factor κB to the nucleus[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:IL-10–deficient mice[3]
-
Dosage:50 µg/0.2 ml saline
-
Administration:I.p.
-
Result:Given systemically effectively modulated inflammatory reactions.
Chemical Information
-
CAS No. 581-05-5
-
Appearance Solid
-
Molecular Weight 1664.88
-
Formula C77H109N21O19S
-
Color White to off-white
-
Synonyms
α-Melanocyte-Stimulating Hormone
-
Sequence
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
-
Sequence Shortening
Ac-SYSMEHFRWGKPV-NH2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Sealed storage, away from moisture and light, under nitrogen
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)
Publications (24)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
Activation of melanocortin-1 receptor signaling in melanoma cells impairs T cell infiltration to dampen antitumor immunity. [Abstract]2023 Sep 15;14(1):5740. PMID: 37714844
α-MSH purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 Sep 15;14(1):5740. [Abstract]
Western blotting of the indicated proteins in B16F10-dCas9 cells transduced with NTC sgRNA or Mc1r sgRNA. Cells were untreated or treated with 1 µM α-MSH (1 µM; 1 h) for 1 h. A representative result is shown from two independent experiments.
-
Phytomedicine
Clematis Tangutica (Maxim.) Korsh. extracts promote melanogenesis via PKA/CREB activation and multi-cytokine inhibition: A novel dual targeting strategy for vitiligo therapy. [Abstract]2026 Apr:153:157963. PMID: 41720011 -
Mater Today Bio
Tetrahedral framework nucleic acids carrying tranexamic acid to alleviate ultraviolet B-induced skin pigmentation. [Abstract]2026 May 27. PMID: 42293393 -
J Hazard Mater
Melanin-mediated accumulation of polycyclic aromatic hydrocarbons in human hair: Insights from biomonitoring and cell exposure studies. [Abstract]2024 May 15:470:134112. PMID: 38537572
α-MSH purchased from MedChemExpress. Usage Cited in: J Hazard Mater. 2024 May 15:470:134112. [Abstract]
α-MSH (0.1 μM; 48 h). Number of B16-F10 cells. Positive group: α-MSH.
-
Acta Pharmacol Sin
Dorsal raphe GABA-ergic neurons regulate the susceptibility to social transfer of pain in mice. [Abstract]2025 Jul;46(7):1892-1904. PMID: 40011629 -
Antioxidants (Basel)
Natural Bioactive Peptides from Tree Peony Flowers: Multifunctional Effects on Skin Antioxidation, Wrinkle Reduction, Moisturization, and Melanin Inhibition. [Abstract]2026 Mar 11;15(3):350. PMID: 41897496 -
Antioxidants (Basel)
Antioxidative Role of Hygrophila erecta (Brum. F.) Hochr. on UV-Induced Photoaging of Dermal Fibroblasts and Melanoma Cells. [Abstract]2022 Jul 2;11(7):1317. PMID: 35883808 -
Free Radic Biol Med
The critical role of glutathione redox homeostasis towards oxidation in ermanin-induced melanogenesis. [Abstract]2021 Nov 20:176:392-405. PMID: 34560247 -
Stem Cell Res Ther
Human amniotic stem cells-derived exosmal miR-181a-5p and miR-199a inhibit melanogenesis and promote melanosome degradation in skin hyperpigmentation, respectively. [Abstract]2021 Sep 10;12(1):501. PMID: 34507619
α-MSH purchased from MedChemExpress. Usage Cited in: Stem Cell Res Ther. 2021 Sep 10;12(1):501. [Abstract]
α-MSH (200 nM; 48 h). The effects of hAMSC-CM or hAESC-CM on tyrosinase enzyme activity are confirmed by treatment with L-DOPA and detection of tyrosinase at 475 nm.
-
Blood Adv
Melanocortin/MC5R axis regulates the proliferation of hematopoietic stem cells in mice after ionizing radiation injury. [Abstract]2023 Jul 11;7(13):3199-3212. PMID: 36920787
α-MSH purchased from MedChemExpress. Usage Cited in: Blood Adv. 2023 Jul 11;7(13):3199-3212. [Abstract]
α-MSH (1 mg/kg; i.p.; once a day for a total of 7 days). Cell cycle analysis of LT-HSCs from the BM of WT mice treated with saline or α-MSH along with vehicle, MK-2206, or PD325901 (n = 6).
-
J Med Chem
Targeting Periplakin of Novel Benzenesulfonamides as Highly Selective Agonists for the Treatment of Vitiligo. [Abstract]2024 Nov 14;67(21):19323-19341. PMID: 39485487 -
-
J Ethnopharmacol
The whitening effect of cuscutin responsible for traditional use of Bergenia purpurascens. [Abstract]2024 May 23:326:117933. PMID: 38382653 -
J Agric Food Chem
2023 Nov 1;71(43):16090-16101. PMID: 37856847 -
Foods
Enzymatic Production of Collagen Oligopeptides from Porcine Skin and Their Structure-Activity Relationships in Anti-Aging and Skin-Whitening Effect. [Abstract]2026 Feb 1;15(3):507. PMID: 41683092 -
Colloids Surf B Biointerfaces
Glabridin-encapsulated liposomes targeting melanocytes through the melanocortin 1 receptor. [Abstract]2025 Jul 24:255:114979. PMID: 40712492
α-MSH purchased from MedChemExpress. Usage Cited in: Colloids Surf B Biointerfaces. 2025 Jul 24:255:114979. [Abstract]
α-MSH (0.3 μmol/L; 72 h). Effects of PT8 on the expression of cAMP signaling pathway-related factors in B16 cells. Relative quantification of MITF mRNA levels through quantitative PCR after treatment with PT8.
-
Bioorg Chem
Melanin resistance of heat-processed ginsenosides from Panax ginseng berry treated with citric acid through autophagy pathway. [Abstract]2024 Nov:152:107758. PMID: 39216197 -
-
J Photochem Photobiol B
3, 7-dihydroxy-2, 4-dimethoxyphenanthrene protects against UVB-induced skin hyperpigmentation via antioxidant and anti-melanogenic mechanisms. [Abstract]2025 Nov:272:113277. PMID: 41106058 -
Photochem Photobiol Sci
The extract of dendrobium Coelonin inhibits PIH induced by AFR CO2 fractional laser combined with UV-B. [Abstract]2025 Oct;24(10):1763-1779. PMID: 41108468 -
J Cosmet Dermatol
Paeoniflorin found in Paeonia lactiflora root extract inhibits melanogenesis by regulating melanin-related signal transduction in B16F10 cells. [Abstract]2023 Oct;22(10):2824-2830. PMID: 37288793 -
Int J Cosmet Sci
Hydrolyzed conchiolin protein inhibits melanogenesis through PKA/CREB and MEK/ERK signalling pathways. [Abstract]2025 Feb;47(1):31-44. PMID: 39128885 -
-
Heliyon
Differentiation of cultured hair follicle neural crest stem cells into functional melanocytes. [Abstract]2024 Aug 7;10(15):e35295. PMID: 39170163
Solvent & Solubility
DMSO : 100 mg/mL (60.06 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : ≥ 12.5 mg/mL (7.51 mM)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Madhuri Singh, et al. C-terminal amino acids of alpha-melanocyte-stimulating hormone are requisite for its antibacterial activity against Staphylococcus aureus. Antimicrob Agents Chemother. 2011 May;55(5):1920-9. [Content Brief]
[2]. M S Kim, et al. Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes. 2000 Feb;49(2):177-82. [Content Brief]
[3]. Lipton JM, et al. Mechanisms of antiinflammatory action of alpha-MSH peptides. In vivo and in vitro evidence. Ann N Y Acad Sci. 1999;885:173-182. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O / DMSO | 1 mM | 0.6006 mL | 3.0032 mL | 6.0064 mL | 15.0161 mL |
| 5 mM | 0.1201 mL | 0.6006 mL | 1.2013 mL | 3.0032 mL | |
| DMSO | 10 mM | 0.0601 mL | 0.3003 mL | 0.6006 mL | 1.5016 mL |
| 15 mM | 0.0400 mL | 0.2002 mL | 0.4004 mL | 1.0011 mL | |
| 20 mM | 0.0300 mL | 0.1502 mL | 0.3003 mL | 0.7508 mL | |
| 25 mM | 0.0240 mL | 0.1201 mL | 0.2403 mL | 0.6006 mL | |
| 30 mM | 0.0200 mL | 0.1001 mL | 0.2002 mL | 0.5005 mL | |
| 40 mM | 0.0150 mL | 0.0751 mL | 0.1502 mL | 0.3754 mL | |
| 50 mM | 0.0120 mL | 0.0601 mL | 0.1201 mL | 0.3003 mL | |
| 60 mM | 0.0100 mL | 0.0501 mL | 0.1001 mL | 0.2503 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.